Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1301–1350 of 34667
On April 24, 2026, during a telephonic discussion with members of the Board of Directors (the “Board”) of Sentient Brands Holdings Inc. (the “Company”), George Furlan informed the Board of his resignation, effective April 24, 2026, from his positions as Interim Chief Executive Officer of the Company and as a member of the Board.
On April 28, 2026, the board of directors (the “Board”) of Streamex Corp. (the “Company”) appointed Mr. Mitchell Young Williams, the Company’s Chief Investment Officer, to serve as a non-independent director of the Board
On March 30, 2026, and in connection with the closing of the acquisition contemplated by the Purchase Agreement and the Board Election Agreement entered on April 1, 2026 (the “ Board Election Agreement ”), the Board of Directors of Parent appointed Steve Girardin as a Class III Director, effective as of the closing, with a term expiring at the annual stockholder meeting in 2029, and under certain circumstances if Steve Girardin leaves the Board prior to such annual meeting, to appoint Dave Girardin as his replacement through the 2029 annual meeting.
On May 4, 2026, the Board of Directors (the "Board") of BARK, Inc. (the "Company") announced the appointment of James Gagne as a member of the Board, effective immediately, as a Class A director for a term expiring at the Company's 2028 annual meeting of stockholders and until his successor is duly elected and qualified.
approved the appointment of Paul Keel to fill the new director position, effective as of July 1, 2026
On May 4, 2026, after more than twenty years of service, Steve Odland informed the Company that he has decided not to stand for reelection to the Board of Directors at the Company’s 2026 Annual Meeting of Shareholders in September.
On April 13, 2026, Irving Minnaker resigned from the Board of Directors (the "Board") of Cycurion, Inc. (the "Company") and from any and all offices that he holds with the Company, effective as from February 14, 2026.
On May 4, 2026, Jerzy (George) Gumulka resigned as a member of the Company’s Board of Directors (the “Board”) . Mr. Gumulka’s resignation from the Board was not a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
On May 4, 2026, the Board agreed to appoint Michal Fisher as an independent member of the Company’s Board.
On April 27, 2026, Charles J. Dockendorff informed Haemonetics Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Shareholders (the “2026 Annual Meeting”).
as of the Effective Time, the Burke & Herbert board of directors appointed current LNKB directors Diane Poillon and Kristen Snyder to the board of the surviving corporation as the LNKB Continuing Directors.
as of the Effective Time, the Burke & Herbert board of directors appointed current LNKB directors Diane Poillon and Kristen Snyder to the board of the surviving corporation as the LNKB Continuing Directors.
On April 29, 2026, Peter K. Shea notified the Company of his decision to resign as a member of the Board of Directors (the "Board"), including from his service on the Company’s Audit Committee.
On April 30, 2026, the Company appointed each of Mr. Thomas D. Davis, the Company’s Chief Executive Officer, and Mr. Craig Pettit to serve as members of the Board to fill the vacancies created by the resignations of Messrs. Peter Shea and Read.
Also, on April 29, 2026, Randolph C. Read notified the Company of his decision to resign as a member of the Board.
On April 30, 2026, the Company appointed each of Mr. Thomas D. Davis, the Company’s Chief Executive Officer, and Mr. Craig Pettit to serve as members of the Board to fill the vacancies created by the resignations of Messrs. Peter Shea and Read.
On May 1, 2026, the Board of Directors (the “Board”) of Stock Yards Bancorp, Inc. (the “Company”) appointed Scott P. Davis to serve as a member of the Board, effective May 1, 2026, in connection with the completion of the Company’s previously announced acquisition of Field & Main Bancorp, Inc.
Effective simultaneously with this appointment, Mr. Davis was appointed to serve as a director of Stock Yards Bank & Trust Company (the “Bank”), the Company’s principal banking subsidiary, and to serve on the Bank’s Trust Committee.
On April 27, 2026, the Board appointed Dr. Shao-Lee Lin as the Company’s President and Chief Executive Officer and as a member of the Board, effective as of her commencement of employment with the Company, which began on April 30, 2026
On April 29, 2026, the Board of Directors (the “Board”) of Flowco Holdings Inc. (the “Company”) appointed J. Hardy Murchison, effective April 29, 2026, to fill a vacancy on the Board.
Thomas M. “Roe” Patterson and C. Richard Vermillion ceased serving as directors of the Company
Jeremy D. Thigpen were elected
Ira H. Green, Jr., Daniel J. Kimes and Jeremy D. Thigpen were elected
Daniel J. Kimes and Jeremy D. Thigpen were elected
C. Richard Vermillion ceased serving as directors of the Company
On May 1, 2026, the Company announced that the Board of Directors of the Company (the “Board”) approved the appointment of Sharon Price John as Chief Executive Officer and President of the Company and a member of the Board, effective June 15, 2026
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On April 30, 2026, Atish Shah notified the Company of his decision to not stand for reelection to the Board at the Company's 2026 annual meeting of shareholders, to be held on June 18, 2026 (the "Annual Meeting").
On April 27, 2026, the Board of Directors ("Board") of Dave & Buster's Entertainment, Inc. (the "Company") appointed Charles H. Protell, 51, to the Board and to the Audit Committee of the Board, in each case effective April 27, 2026.
On May 1, 2026, Winnebago Industries, Inc. (the “Company”) announced the appointment of Emily R. Silver to its Board of Directors (“Board”) effective May 1, 2026.
On April 27, 2026, Robert Lipstein notified the Onfolio Holdings Inc. (the “Company”) Chair of the Board that he intended to resign as a director of the Company effective May 31, 2026.
Bilge Ogut resigned from the Board, including any committees thereof, effective immediately.
ch of Burke & Herbert and Burke & Herbert Bank, effective as of the Effective Time, took such actions as necessary to appoint the LNKB Continuing Directors and the LINKBANK Continuing Directors.
ch of Burke & Herbert and Burke & Herbert Bank, effective as of the Effective Time, took such actions as necessary to appoint the LNKB Continuing Directors and the LINKBANK Continuing Directors.
The Board of Directors (the “Board”) of Match Group, Inc. (the “Company”) appointed Raina Moskowitz to the Board, effective as of the Company’s 2026 annual meeting of stockholders (the “2026 Annual Meeting”), with a term expiring at the Company’s 2027 annual meeting of stockholders (the “2027 Annual Meeting”).
Pamela S. Seymon as a member of the Board, which is also effective as of the 2026 Annual Meeting.
Manuel Bronstein will stand for election to the Board at the 2026 Annual Meeting for a term that expires at the 2027 Annual Meeting.
In addition, on April 29, 2026, Kurt Azarbarzin, Vince Burgess and Federica O’Brien (the “ Resigning Directors ”) each tendered his or her resignation from the Board...
In addition, on April 29, 2026, Kurt Azarbarzin, Vince Burgess and Federica O’Brien (the “ Resigning Directors ”) each tendered his or her resignation from the Board...
On April 29, 2026, in connection with the Resigning Directors’ resignations, the Board appointed Guido Neels as a Class II director, with a term expiring at the 2027 Annual Meeting of the Company, and Guy Nohra and Paul Thomas as Class III directors...
In addition, on April 29, 2026, Kurt Azarbarzin, Vince Burgess and Federica O’Brien (the “ Resigning Directors ”) each tendered his or her resignation from the Board...
On April 29, 2026, in connection with the Resigning Directors’ resignations, the Board appointed Guido Neels as a Class II director, with a term expiring at the 2027 Annual Meeting of the Company, and Guy Nohra and Paul Thomas as Class III directors...
On April 29, 2026, in connection with the Resigning Directors’ resignations, the Board appointed Guido Neels as a Class II director...
On April 27, 2026, Christopher Winkle notified the Company of his resignation from the Board, effective May 31, 2026.
On April 28, 2026 (the “ Appointment Date ”), Dr. Laura Sepp-Lorenzino was appointed to the board of directors (the “ Board ”) of Lexeo Therapeutics, Inc.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.